CEO Invests $720K at Premium, Securing 83.83% Voting Power

summarizeSummary

Haoxi Health Technology's CEO, Zhen Fan, is purchasing $720,000 worth of Class B ordinary shares at a premium to market price, significantly increasing his voting power to 83.83% and providing crucial working capital.

check_boxKey Events

• CEO Personal Investment

  CEO Zhen Fan is purchasing 40,000,000 Class B ordinary shares for an aggregate price of $720,000.

• Premium Pricing

  The shares are priced at $0.018 per share, representing a 101.12% premium to the closing price of the company's Class A ordinary shares on May 18, 2026.

• Increased Voting Control

  Following the transaction, the CEO will beneficially own approximately 83.83% of the company's aggregate voting power.

• Working Capital Infusion

  The net proceeds from the sale will be used for working capital and general corporate purposes, providing a crucial financial boost after recent reports of significant losses.

auto_awesomeAnalysis

This filing details a critical capital injection for Haoxi Health Technology, a company that recently reported massive net losses and extreme share dilution. CEO Zhen Fan's personal investment of $720,000, made at a premium to the market price, signals strong conviction in the company's future. This capital provides essential working capital and significantly increases the CEO's voting power to over 83%, granting him near-total control and aligning his interests directly with the company's survival and potential turnaround. This transaction follows a recent $6.46 million registered direct offering, indicating a concerted effort to stabilize the company's financial position.